Contents

Current Drug Targets, Volume 6 - Number 6

Editorial [Hot Topic:Strategies for Molecular-Based Treatment of Hematological Malignancies (Guest Editor: Per Ole Iversen)]

, 6(6): 629

Per O. Iversen


DOI: 10.2174/1389450054863680




Proteomics in Acute Myelogenous Leukaemia (AML): Methodological Strategies and Identification of Protein Targets for Novel Antileukaemic Therapy

, 6(6): 631 - 646

G. Sjoholt, N. Anensen, L. Wergeland, E. Mc Cormack, O. Bruserud and B. T. Gjertsen


DOI: 10.2174/1389450054863671




Ribozymes, DNAzymes and Small Interfering RNAs as Therapeutics

, 6(6): 647 - 653

M. Sioud and P. O. Iversen


DOI: 10.2174/1389450054863653




Protein Kinase A (PKA) - A Potential Target for Therapeutic Intervention of Dysfunctional Immune Cells

, 6(6): 655 - 664

B. S. Skalhegg, A. Funderud, H. H. Henanger, T. T. Hafte, A. C. Larsen, A.- K. Kvissel, S. Eikvar and S. Orstavik


DOI: 10.2174/1389450054863644




Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans

, 6(6): 665 - 682

K. Fjeldstad and S. O. Kolset


DOI: 10.2174/1389450054863662




Angiogenesis and Hemostasis in Hematological Neoplasias

, 6(6): 683 - 699

H. Negaard, A. Dahm, P. M. Sandset, P. O. Iversen and B. Ostenstad


DOI: 10.2174/1389450054863699




Identification of New Targets for Therapy of Osteolytic Bone Disease in Multiple Myeloma

, 6(6): 701 - 711

O. Hjertner, T. Standal, M. Borset, A. Sundan and A. Waage


DOI: 10.2174/1389450054863716




Strategies for Biology- and Molecular-Based Treatment of Myelodysplastic Syndromes

, 6(6): 713 - 725

E. H. Lindberg


DOI: 10.2174/1389450054863707




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science